Our core team and advisory board comprises of world-class individuals experienced in bringing novel rhinology tools and cutting-edge biomarker technologies to market to improve patient outcomes and reduce healthcare costs
Diag-Nose was formally founded in 2020 after our world-class team of otolaryngologists, bioengineers and entrepreneurs met at the Stanford Medicine EENT Innovation Program.
Our main insight revolved around the distinct inflammatory pathways present in patients suffering from chronic nasal disorders, despite their complex and heterogenous presentations.
We created the technology to empower physicians, patients and researchers with objective biological insights to enable personalized therapy, improve patient outcomes and reduce healthcare costs
Co-CMO/Founder
Co-CMO/Founder
MSL/Founder
CEO/Founder
CSO
